openPR Logo
Press release

Probiotic IBS Supplements Market Statistical Forecast, Trade Analysis 2024 -The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited.

07-10-2024 11:13 AM CET | Food & Beverage

Press release from: DataM Intelligence 4Market Research

Probiotic IBS Supplements Market Statistical Forecast, Trade

DataM Intelligence has published a new research report on "Probiotic IBS Supplements Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/probiotic-ibs-supplements-market

The Probiotic IBS Supplements market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Probiotics have demonstrated potential in alleviating symptoms of irritable bowel syndrome (IBS). A meta-analysis by the American College of Gastroenterology indicated that probiotics can contribute to improving overall IBS symptoms, including bloating and flatulence. The expansion of the probiotics market is driven by increased consumer awareness of the benefits for gut health, a rising prevalence of digestive disorders, and ongoing research into the broader health impacts of probiotics beyond digestion. This combination of factors underscores the growing interest and demand for probiotics as a supportive therapy in managing digestive health and related conditions like IBS.

Forecast Growth Projected:

The Global Probiotic IBS Supplements Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2030. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Probiotic IBS Supplements Market: The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited, Unique Biotech Limited, Projoy Pvt Ltd, Pure NSM - Nutritional Supplement Manufacturers, Inc., Nature's Bounty, Hyperbiotics, Advanced Vital Enzymes Private Ltd and Wren Laboratories Ltd.

Segment Covered in the Probiotic IBS Supplements Market:

By Strain: Lactobacillus, Bifidobacterium, Other.

By Form: Tablet, Capsules, Liquid, Powder, Others.

By Distribution Channel: Supermarkets/Hypermarkets, Pharmacy/Health Stores, Online Stores, Other.

By End-User: Infants, Children, Adults, Seniors.

Regional Analysis:

The global Probiotic IBS Supplements Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/probiotic-ibs-supplements-market

Regional Analysis:

The global Probiotic IBS Supplements Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Probiotic IBS Supplements Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Probiotic IBS Supplements manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Probiotic IBS Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/probiotic-ibs-supplements-market

FAQs

How big is the Probiotic IBS Supplements Market?

The Probiotic IBS Supplements Market size was USD 29.12 million in 2023. It is expected to reach USD 48.79 million by 2031.

How fast is the Probiotic IBS Supplements Market growing?

The Probiotic IBS Supplements Market will exhibit a CAGR of 7.65% during the forecast period, 2023-2031.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Probiotic IBS Supplements Market Statistical Forecast, Trade Analysis 2024 -The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited. here

News-ID: 3574062 • Views:

More Releases from DataM Intelligence 4Market Research

United States Biofuels Market Set to Soar: Innovations and Sustainability Drive Global Growth 2025 | Top key players - ADM, Cargill, Incorporated, Chevron Corporation.
United States Biofuels Market Set to Soar: Innovations and Sustainability Drive …
Market Size and Growth: The Global Bio Fuels Market size was US$ 153.88 billion in 2024 and is expected to reach US$ 252.19 billion in 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032). The Biofuels Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions
United States Food Encapsulation Market Poised for Expansion Amidst Clean Label and Health Trends 2025 | Major key players - Aveka Group, ABCO Laboratories, Inc., Balchem Corporation.
United States Food Encapsulation Market Poised for Expansion Amidst Clean Label …
Market Overview: The Food Encapsulation Market is expected to grow at a CAGR of 8% during the forecast period 2024-2031. The Food Encapsulation Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it
United States Precious Metal Market Poised for Strong Growth Amid Rising Investment Demand 2025 | Top key players - Newmont Corporation, Barrick Gold Corporation, Norilsk Nickel.
United States Precious Metal Market Poised for Strong Growth Amid Rising Investm …
Market Size and Growth: The Global Precious Metal Market size reached US$ 209.4 billion in 2023 and is expected to reach US$ 300.3 million by 2031, growing with a CAGR of 5.2% during the forecast period 2024-2031. The Precious Metal Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed
United States Anti-Obesity Drugs Market Set for Robust Growth with Rising Global Obesity Concerns 2025 | Top key players - Eli Lilly and Company, Bayer AG, Bristol-Myers Squibb.
United States Anti-Obesity Drugs Market Set for Robust Growth with Rising Global …
Market Size and Growth: The Global Anti-Obesity Drugs Market size reached US$ 2.5 billion in 2022 and is expected to reach US$ 43.7 billion by 2030 growing with a CAGR of 45.5% during the forecast period 2024-2031. The Anti-Obesity Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed

All 5 Releases


More Releases for IBS

Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs. 👉 Download our latest market insights:
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide. A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L
HaCon and IBS combine expertise in railway operation
Hanover (2010-07-06). Two Hanoverian companies now combine their expertise in questions of railway operations: With effect from 1 July 2010, the HaCon Ingenieurgesellschaft mbH, took over the engineering firm for railway operating systems (Ingenieurbüro für Bahnbetriebssysteme GmbH – IBS). This way HaCon expanded its services to include the areas operation simulation, vehicle and personnel planning and construction operations planning. This also includes consulting services concerning railway systems issues, such as travel
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011. The new bulkers, each with a capacity of 176,000 dwt, will be equipped